Tovecimig (a DLL4 x VEGF-A bispecific antibody) in combination with paclitaxel demonstrated a highly statistically significant improvement versus paclitaxel alone in the key secondary endpoint of ...
Positive Full Results from Phase 1a Trial of Anti-TSLP/IL-4Rα Bispecific Antibody ATI-052 Exceed Aclaris’ Target Profile, ...
George takes a look at the next game from developer Housemarque, the bullet-hell roguelike Saros. How does it stack up? Here ...
The latest Nintendo Download update for North America has arrived, and it's bringing new games galore to the eShop in your ...
The Challenge of Safe Recovery in Elderly Thoracic PatientsAs the elderly population grows, so does the prevalence of lung ...
The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.37 billion (USD 8.5 million 1) ...
Discusses Modulation and Combination Strategies in ER-Positive Metastatic Breast Cancer and the Role of Lasofoxifene April 29, ...
9d
I'm a Louisville Native and Worked at Churchill Downs—Here's Exactly How to Do the Kentucky Derby
A VERANDA editor and Louisville native shares where to stay, what to wear, and how to experience the most stylish two minutes ...
YouTube on MSNOpinion
The 12-year-old, the statin, and the story we tell ourselves
A 12-year-old athlete prescribed a statin sparked a deeper question: are we treating numbers or people? This letter unpacks ...
The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.37 billion (USD 8.5 million1) in five R&D ...
Morning Overview on MSN
Immunotherapy trial reports 100% remission in a specific rectal cancer group
Every patient in a small clinical trial at Memorial Sloan Kettering Cancer Center saw their rectal cancer vanish after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results